Valeant to reduce debt further, Takeda announces Q3 results & more — 6 GI company key notes

Here are six updates on GI companies from the past week.

Advertisement

Vizient bestowed its 2017 Innovative Technology designation on Pentax Medical’s slim linear ultrasound endoscope.

Valeant CEO Joseph Papa said the company intends to pay down an additional $125 million in senior secured term loans with cash on hand.

Takeda reported net revenues of $881.4 billion yen ($7.71 billion) in its third quarter fiscal year 2017 results.

CapsoVision earned a CE Mark for its CapsoCam Plus System for patients 2 years old and older.

Boston Scientific reported net sales of $2.22 billion in its third quarter fiscal year 2017 results.

U.S.-based gastroenterologists once again selected IM HealthScience’s IBgard as their No. 1 recommended peppermint oil for IBS, according to a QuintilesIMS survey.

More articles on gastroenterology: 
GI leader to know: Dr. Christie Choi of Texas Digestive Disease Consultants
8 GI centers to know for October
Stock market week-in-review for 5 large GI companies — Oct. 23-27

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

  • Birmingham (Ala.) Gastroenterology has opened a clinic in Jasper, Ala., expanding access to digestive health services in the region, the…

  • Premier Health Partners has acquired Dayton, Ohio-based Digestive Specialists, according to a notice posted on the website of law firm…

Advertisement

Comments are closed.